Arrhythmias in congenital heart disease: a position paper of the European Heart Rhythm Association (EHRA), Association for European Paediatric and Congenital …

A Hernandez-Madrid, T Paul, D Abrams, PF Aziz… - EP …, 2018 - academic.oup.com
The population of patients with congenital heart disease (CHD) is continuously increasing
with more and more patients reaching adulthood. A significant portion of these young adults …

[HTML][HTML] Arrhythmias and conduction disorders associated with atrial septal defects

MR Williams, JC Perry - Journal of Thoracic Disease, 2018 - ncbi.nlm.nih.gov
Atrial septal defects (ASDs) are the most common form of congenital heart disease. There
are 4 embryologic types of ASDs, and rhythm considerations vary based on type. ASDs have …

ASSURED clinical study: new GORE® CARDIOFORM ASD occluder for transcatheter closure of atrial septal defect

RJ Sommer, BA Love, JA Paolillo… - Catheterization and …, 2020 - Wiley Online Library
Objective Assess clinical performance of a new device for transcatheter closure of atrial
septal defect (ASD). Background Previously‐approved ASD Closure devices have known …

Atrial fibrillation following transcatheter atrial septal defect closure: a systematic review and meta-analysis

JD Himelfarb, H Shulman, CJ Olesovsky, RK Rumman… - Heart, 2022 - heart.bmj.com
Objective The ostium secundum atrial septal defect (ASD) is among the most common
congenital cardiac anomalies diagnosed in adulthood. A known complication of …

Long-term outcomes after atrial septal defect transcatheter closure by age and against population controls

L Abrahamyan, C Dharma, S Alnasser, J Fang… - Cardiovascular …, 2021 - jacc.org
Objectives The long-term outcomes after transcatheter closure of atrial septal defects (ASD)
in adults are reported and compared between age groups and against population control …

Mid-Term Electrical Remodeling after Percutaneous Atrial Septal Defect Closure with GCO Device in a Pediatric Population

J Fumanelli, S Garibaldi, B Castaldi… - Journal of Clinical …, 2023 - mdpi.com
Background and aim: The GORE® CARDIOFORM (GCO) septal occluder is an atrial septal
defect/patent foramen ovale closure device with theoretical advantages over other …

Efficacy of catheter ablation for paroxysmal atrial fibrillation in patients with atrial septal defect: a comparison with transcatheter closure alone

K Nakagawa, T Akagi, S Nagase, Y Takaya… - EP …, 2019 - academic.oup.com
Aims There is no valid treatment strategy for addressing paroxysmal atrial fibrillation (AF) in
patients with unclosed atrial septal defect (ASD). We aimed to assess the efficacy of catheter …

[HTML][HTML] Long-term results of the atrial septal defect occluder ASSURED trial for combined pivotal/continued access cohorts

AM Qureshi, RJ Sommer, G Morgan, JA Paolillo… - JACC: Cardiovascular …, 2024 - Elsevier
Abstract Background The GORE CARDIOFORM ASD Occluder (GCA, WL Gore &
Associates) was approved in 2019 for ostium secundum atrial septal defect (ASD) closure …

Outcome of transcatheter atrial septal defect closure in a nationwide cohort

V Muroke, M Jalanko, J Haukka, J Hartikainen… - Annals of …, 2023 - Taylor & Francis
Background Transcatheter (TC) atrial septal defect (ASD) closure has been the mainstay of
therapy for secundum-type ASDs for over 20 years. Aims This nationwide cohort evaluated …

Arrhythmic Risk and Treatment after Transcatheter Atrial Septal Defect Closure

S Deaconu, A Deaconu, G Marascu, MO Stanculescu… - Diagnostics, 2023 - mdpi.com
Atrial septal defect (ASD) represents the most common congenital heart defect identified in
adulthood. Atrial and ventricular geometric remodeling due to intracardiac shunt increase …